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Abstract
Some species of mushrooms in the genus Amanita are ex-
tremely poisonous and frequently fatal to mammals includ-
ing humans and dogs. Their extreme toxicity is due to ama-
toxins such as α- and β-amanitin. Amanita mushrooms also 
biosynthesize a chemically related group of toxins, the phal-
lotoxins, such as phalloidin. The amatoxins and phallotox-
ins (collectively known as the Amanita toxins) are bicyclic 
octa- and heptapeptides, respectively. Both contain an un-
usual Trp-Cys cross-bridge known as tryptathionine. We have 
shown that, in Amanita bisporigera, the amatoxins and phallo-
toxins are synthesized as proproteins on ribosomes and not by 
nonribosomal peptide synthetases. The proproteins are 34–35 
amino acids in length and have no predicted signal peptides. 
The genes for α-amanitin (AMA1) and phallacidin (PHA1) are 
members of a large family of related genes, characterized by 
highly conserved amino acid sequences flanking a hypervari-
able “toxin” region. The toxin regions are flanked by invariant 
proline (Pro) residues. An enzyme that could cleave the pro-
protein of phalloidin was purified from the phalloidin-pro-
ducing lawn mushroom Conocybe apala. The enzyme is a ser-
ine protease in the prolyl oligopeptidase (POP) subfamily. The 
same enzyme cuts at both Pro residues to release the linear 
hepta- or octapeptide.
Keywords: amanitin, halloidin, phallacidin, prolyl oligopepti-
dase, Conocybe, Amanita
Introduction
Certain species in the genus Amanita account for 
more than 90% of the fatal mushroom poisonings 
worldwide. Amatoxins such as α-amanitin (Figure 1A) 
are the poisonous compounds in species of Amanita sect, 
Phalloideae. The human LD50 for α-amanitin is ~0.1 mg/
kg, and one mushroom can contain a fatal dose of 10–12 
mg.1 There are several forms of amatoxins, which differ 
in their pattern of hydroxylation and/or containing Asn 
instead of Asp. Amatoxins are also made by several spe-
cies of mushroom in other unrelated genera.
Amatoxins survive the human digestive tract and en-
ter liver cells, where they inhibit RNA polymerase II.2 
Without prompt intervention, amatoxins cause irrevers-
ible liver failure and death in 3–7 days. Liver transplants 
are often the only treatment option if more than 48 h has 
elapsed since ingestion.
Species of Amanita that make amatoxins also make a 
related family of cyclic peptides known as phallotoxins, 
such as phalloidin and phallacidin (Figure 1B). Phallo-
toxins are also made by Conocybe apala (=C. albipes or C. 
lactea).3 The phallotoxins contain seven instead of eight 
amino acids, a sulfide (thioether) instead of a sulfox-
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ide in the cross-bridge between Trp and Cys, and one 
amino acid with the D configuration. Phallotoxins are 
toxic to mammals if injected but are not absorbed by the 
digestive tract.1 Phallotoxins stabilize F-actin, and fluo-
rescent conjugates of phalloidin are commonly used to 
study the actin cytoskeleton.
We recently showed that the amatoxins and phallo-
toxins are biosynthesized on ribosomes, and not, like all 
other known fungal cyclic peptides, by nonribosomal 
peptide synthetases.4 The genes were discovered by ge-
nomic survey sequencing using 454 pyrosequencing of 
Amanita bisporigera, the “destroying angel” mushroom 
(see Figure 2). In addition to AMA1 (for α-amanitin) and 
PHA1 (for phallacidin), the genome of A. bisporigera con-
tains a large family of related genes, which we call the 
MSDIN family. In all members of this family, the pro-
proteins are ~34–39 amino acids in length and lack pre-
dicted signal peptides. The regions of these proproteins 
that contain the amino acid sequences found in the ma-
ture toxins are 6–10 amino acids in length and are hy-
pervariable compared to the surrounding amino acid 
sequences (see Figure 3). These compounds are among 
the smallest known ribosomally synthesized cyclic pep-
tides. In all family members, a proline (Pro) residue is 
always the immediate upstream amino acid and also 
the last amino acid in the predicted hypervariable re-
gions. All known amatoxins and phallotoxins and all 
predicted MSDIN peptides contain at least one Pro res-
idue, but only the amatoxins and phallotoxins contain 
Trp and Cys, and so only these subfamily members can 
form tryptathionine. Several monocyclic hexa- and de-
capeptides have been isolated from A. phalloides.1 All 20 
proteinogenic amino acids have been found at least once 
in one of the MSDIN family members of A. bisporigera. 
We have also used PCR to amplify members of the MS-
DIN family from A. phalloides (the death cap mushroom) 
and A.ocreata.4
Processing of the Amanita Toxins
Following translation, subsequent necessary steps 
in Amanita toxin biosynthesis include proteolytic ex-
cision, cyclization, hydroxylation, Trp-Cys (tryptathi-
onine) cross-linking, and, in the case of the phallotox-
ins, epimerization of one amino acid. These steps do not 
necessarily occur in that order. Amanita toxin biosyn-
thesis might also require genes encoding proteins for 
export and regulation, as is often seen for other fungal 
secondary metabolites (e.g., Reference 5). Cyclization 
might occur before or after tryptathionine biosynthesis.
Figure 1. A: Structure of α-amanitin (an amatoxin). B: Structure of phallacidin (a phallotoxin). All amino acids have the L configu-
ration except D-hydroxyAsp in phallacidin (D-Thr in phalloidin).
Figure 2. Amanita bisporigera collected in Michigan in 2009. 
This deadly white mushroom, known as the “destroying an-
gel,” is a native of North America and biosynthesizes amatox-
ins and phallotoxins.
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It is currently difficult to address the biochemistry 
of the post-translational processing steps, because the 
uniqueness of the Amanita system means that other ribo-
somal peptide biosynthetic systems, such as cyclotides 
or patellamides, cannot serve as precedents. Also, the 
complete genome of any toxin-producing, Amanita spe-
cies is not available.
A common feature of fungal secondary metabo-
lites, at least in ascomycetes and some basidiomycetes, 
is clustering of the genes in the pathway. It is impor-
tant to note that eukaryotic gene clustering is quite dis-
tinct from the clustering found in bacterial operons; al-
though both types comprise 3–15 genes each separated 
by 0.2–2 kb, in eukaryotic clusters each gene has its own 
promoter, that is, there are no polycistronic mRNAs. 
Typical fungal secondary metabolite gene clusters con-
tain biosynthetic genes, genes for transporters (metabo-
lite efflux carriers or pumps), and pathway-specific tran-
scription factors that positively regulate the other genes 
of the cluster.5–7 Preliminary evidence suggests that 
some of the MSDIN genes are clustered with some po-
tential biosynthetic genes (unpublished results), but our 
genome survey sequence data of A. bisporigera are still 
too incomplete to draw any solid conclusions.
Proteolytic Cleavage of the Proprotein
As noted earlier, the hypervariable regions of the MS-
DIN family have invariant flanking Pro residues (see 
Figure 3). Consideration of the known Pro-specific pep-
tidases 8 suggested that a prolyl oligopeptidase (POP) cat-
alyzes the initial biosynthetic step. POPs are widespread 
in animals, plants, bacteria, and fungi (except, strangely, 
ascomycetes) and cleave at internal Pro residues of small 
proteins (<35 amino acid). A. bisporigera has two POP 
genes, one of which is found only in Amanita sect. Phal-
loidae (Reference 4 and unpublished observations). Other 
fully sequenced (toxin nonproducing) fungi including 
Coprinus cinerea, Phanerochaete chrysosporium, and Laccaria 
bicolor appear to each have a single POP gene.
To determine the enzyme that was responsible for the 
proteolytic processing of the Amanita toxins, it was pu-
rified from mushroom extracts. Amanita species them-
selves are transient in availability (they cannot be cul-
tured in the laboratory) and therefore we used Conocybe 
apala as the starting material, a mushroom which grows 
abundantly in well-watered lawns of the Michigan State 
University campus (see Figure 4). It is possible to collect 
kilogram quantities of C. apala in a few days. The mush-
rooms continue to emerge daily throughout the sum-
mer. C. apala makes phalloidin (but not amanitin)3 and 
therefore must contain the enzyme (or enzymes) that 
cleave the phalloidin proprotein.
Using standard protein purification methods, we 
identified an enzyme from C. albipes that cleaves a syn-
thetic phalloidin peptide.10 During the early stages of 
purification, it became apparent that the cleavage en-
zyme was copurifying with activity against the POP 
substrate Z-Gly-Pro-pNA and was inhibited by the spe-
cific POP inhibitor Z-Pro-Prolinal. The cleavage enzyme 
was purified to homogeneity and subjected to mass 
spectrometric peptide analysis. Combined with the full 
amino acid sequence deduced from a cDNA, we identi-
fied the protein as a member of the POP family of serine 
proteases.9 The pure enzyme cuts at both Pro residues 
in the synthetic phalloidin peptide to release the mature 
linear peptide, preferentially cutting at the Pro closer to 
the carboxy terminus before cutting at the Pro closer to 
the amino terminus (see Figure 5).
In regard to the mechanism of cyclization of the Am-
anita toxins, there are some potentially relevant prec-
edents presented in other works in this volume. As 
shown elsewhere in this volume, trypsin and other pro-
teases are capable of making as well as breaking pep-
tide bonds.11, 12 It is very likely that a protease or prote-
aselike enzyme catalyzes the cyclization of the Amanita 
toxins. However, to date, no chromatographic or mass 
spectrometric evidence was obtained for any cyclized 
product during incubation of toxin precursors with 
POP, and therefore cyclization is probably not catalyzed 
by POP. In regard to the sequence of processing steps, 
cyclication might occur after formation of the Trp-Cys 
crossbridge (tryptathionine), because this would facili-
tate cyclization by bringing the N and C termini of the 
nascent peptide closer together.
Figure 3. WebLogo alignment of 15 members of the “MSDIN” 
family (named for the first five highly conserved amino acids). 
The height of the amino acid at each position represents its de-
gree of conservation. The MSDIN family encodes the amatox-
ins and phallotoxins and is also predicted to encode a variety 
of unknown peptides within the hypervariable central region 
(amino acids 11–20), which is 6–10 amino acids in length (Xs 
have been inserted in the hypervariable regions of less than 10 
amino acids to emphasize the conservation of the carboxy ter-
minus of the MSDIN peptides). As defined here, the “hyper-
variable” region includes the carboxy-terminal Pro, which is 
completely conserved in the MSDIN family as well as being a 
constituent of the mature toxins. Based on cDNA sequences, 
the M (Met) of MSDIN is the translational start codon. Amino 
acids 35–39 are not shown, because there is an intron (exper-
imentally established for AMA1 and PHA1; deduced for the 
others) that interrupts the third to the last codon. (Originally 
published in Luo et al. J Biol Chem 284 [2009], pp. 18070–18077. 
Copyright © the American Society for Biochemistry and Mo-
lecular Biology.)
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Histology of Toxin Biosynthesis
Mushrooms are multicellular organisms with many 
specialized cell types. There are many examples of 
mushroom toxins and many examples of chemically 
specialized cell types in mushrooms.13 However, in only 
a few cases, is there any direct evidence connecting the 
two, that is, a specific cell type with a specific metabo-
lite. Do the cell types that show differential staining or 
morphology (consistent with a metabolic specializa-
tion of some sort) serve as the sites of toxin biosynthe-
sis and/or storage?14 Two examples of specialized cell 
types in toxic mushrooms are shown in Figure 6. The 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. A: Collecting Conocybe apala (formerly C. lactea or 
C. albipes) from watered lawns on the campus of Michigan 
State University. B: C. apala. The mushrooms are ~8 cm tall. 
C: High magnification of secretory cells with attached liquid 
droplets from a culture of C. apala established in our labora-
tory. The droplets are not membrane-bound and are easily 
washed off. For more pictures of C. apala secretory cells, see 
http://www.uoguelph.ca/~gbarron/2008/conocybe.htm 
and Reference 9.
Figure 5. Time course of cleavage of a synthetic phalloidin 
precursor (substrate: MSDINATRLPAWLATCPCAGDD). Pu-
rified POP from C. apala was incubated with the substrate for 
the indicated times. Products were separated by HPLC and 
quantitated by their absorbance at 280 nm. The intermediate 
was identified as MSDINATRLPAWLATCP and the product 
as AWLATCP by mass spectrometry. No evidence for a car-
boxy-terminal intermediate (AWLATCPCAGDD) was found. 
Dithiothreitol was included in the enzyme buffer to prevent 
oxidation of the two Cys residues (Originally published in Luo 
et al. J Biol Chem 284 [2009], pp. 18070–18077. Copyright © the 
American Society for Biochemistry and Molecular Biology).
Figure 6. Examples of anatomically and biochemically spe-
cialized cells in mushrooms. A: “Inocybe sp. involved in a fa-
tal poisoning case of a young dog. The encrusted cystidia 
stand up on the gill edges.” The abundant brown circles are 
basidiospores; http://www.flickr.com/photos/cornell-
fungi/2829688392/ . B: Cystidia of Russula. These contain un-
known insecticidal compound(s). The droplets (arrow) are not 
membrane bound and the contents adhere to glass. The drop-
let is is ~10 μm in diameter (from Reference 15; reprinted with 
permission).
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cystidia of a poisonous Inocybe species are large and 
appear to be free of cytoplasm and could be the site 
of storage of the toxic compounds produced by this 
mushroom (Figure 6A). The mushroom Russula bella 
has a specialized cell type that contains unknown me-
tabolites toxic to insects15 (Figure 6B). Such specialized 
cell types could be sites of biosynthesis and/or stor-
age sites. C. apala, which makes phallotoxins and from 
which we purified POP, also has specialized cells that 
appear to be sites of biosynthesis and/or accumulation 
of specialized secondary metabolites. These structures 
could contain phalloidin, but to the best of our knowl-
edge, this has not been addressed experimentally9 (Fig-
ure 4C).
Amanita Toxin Biosynthesis in Context
Small, modified, ribosomally synthesized, and bi-
ologically active peptides have been identified from 
many eukaryotic and prokaryotic sources, including 
bacteria, spiders, snakes, cone snails, plants, and am-
phibian skin.16–20 Like the Amanita toxins, these peptides 
are synthesized as precursor proteins and often undergo 
post-translational modifications similar to those of the 
Amanita toxins, such as cyclization, hydroxylation, and 
epimerization.
The cone snail toxins (conotoxins) are 12–40 amino 
acids. Like the Amanita toxins, the cone snail tox-
ins exist as gene families, the members of which have 
hypervariable regions (corresponding to the amino 
acids present in the mature toxins) and conserved re-
gions found in all members.18 Conotoxins and Ama-
nita toxins differ in several key respects. First, the Am-
anita toxins are smaller (7–10 amino acids vs. 12–40 for 
the conotoxins).21 Second, the mature conotoxins are 
at the carboxy termini of the preproproteins and are 
predicted to be cleaved by a protease that cuts at ba-
sic amino acids (Arg or Lys). In contrast, the mature 
Amanita toxin sequences are internal to the propro-
tein and are predicted to require two cleavages by one 
or more Pro-specific peptidases. Third, the conotoxins 
are “cyclized” not by true head-to-tail peptide bonds 
but rather by multiple disulfide bonds, and the Ama-
nita toxins do not have disulfide bonds. Therefore, we 
do not predict the involvement of a protein disulfide 
isomerase as has been found for cone snail toxins and 
cyclotides.21, 22 However, it is not impossible that the 
formation of the Trp-Cys bond in Amanita toxins is cat-
alyzed by an unusual disulfide isomerase. Fourth, the 
conotoxin preproproteins have signal peptides to di-
rect secretion of the proprotein into the venom duct, 
whereas the Amanita toxins are not secreted 23 and their 
proproteins lack predicted signal peptides.
Cyclotides such as kalata B1 are 28–37 amino acids 
in size.16, 20 The precursor structure contains an N-ter-
minal signal peptide followed by a proprotein region 
and a conserved “N-terminal repeat region” contain-
ing a highly conserved domain of ~20 amino acids, one 
to three cyclotide domains, and a short C-terminal se-
quence. An Asn-endopeptidase is responsible for re-
moving the C-terminal peptide from the proprotein and 
cyclizing the peptide,24 but the protease that cuts the 
N-terminus is apparently not known. The mature cy-
clotides are true head-to-tail cyclic peptides but are also 
held in rigid conformations by multiple disulfide bonds. 
The cyclotides and the Amanita toxins are both eukary-
otic in origin, but differ in size, gene organization, and 
method of processing, and by the absence of disulfide 
bonds in the Amanita toxins.
In the recent years, a number of ribosomally encoded 
cyclic peptide secondary metabolites have been de-
scribed from prokaryotes.19 These include lantibiotics, 
thiocillins, thiomuracins, microcins, microcyclamides, 
and cyanobactins, such as patellamides, streptolysin, 
and tricyclic depsipeptides. Bacterial autoinducing pep-
tides (AIPs), which are 7–9 amino acids, mediate quo-
rum sensing by certain human pathogenic Gram-pos-
itive bacteria.25 AIPs are posttranslationally cyclized 
by the formation of a thiolactone between the carboxyl 
group of the C-terminal amino acid and an internal Cys. 
AIP proproteins are processed at the C-terminus by 
agrB with simultaneous condensation to form the thio-
lactone ring.25
Lantibiotics such as nisin, subtilin, and cinnamy-
cin, are produced by species of Lactobacillus, Strepto-
coccus, and other bacteria. They contain 19–38 amino 
acids and are characterized by the presence of lanthio-
nine, which is formed biosynthetically by dehydration 
of an Ala residue followed by intramolecular addition 
of Cys.26 The lantibiotics are similar to the Amanita tox-
ins in containing a modified, cross-linked Cys residue. 
However, the Cys in the Amanita toxins is cross-linked 
to a Trp residue instead of Ala as in the case of the lan-
tibiotics. Microcin J25 is a 21-amino acid peptide cy-
clized between an N-terminal Gly or Cys residue and 
an internal Glu or Asp residue. It is produced by E. coli; 
other enterobacteria produce related peptides. Process-
ing of the primary translation product (58 amino ac-
ids) involves cleavage of a 37-residue leader peptide 
and cyclization. The maturation reaction requires ATP 
for amide bond formation.27 There are no orthologs of 
mcjA or mcjB in any available fungal genome, includ-
ing A. bisporigera.
Patellamides and other cyanobactins are produced 
by cyanobacterial symbionts of marine ascidians.19, 28, 
29 Like the Amanita toxins, cyanobactins are small (eight 
amino acids) and are cleaved internally from their pro-
proteins. Unlike the Amanita toxins, the primary trans-
lation products of the cyanobactin contain two toxin 
“cassettes,” each of which gives rise to an individual cy-
anobactin.28 The cyanobactins are post-translationally 
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modified differently from the Amanita toxins, in partic-
ular, by heterocyclization. The patellamides are cleaved 
from their proproteins by a subtilisinlike protease 
(PatA) and cyclized by PatG.30 PatA recognizes flanking 
conserved amino acids, but cleavage occurs at a Ser res-
idue instead of Pro as in the case of the Amanita toxins. 
The amino acids that are conserved up and downstream 
of the hypervariable toxin region in the MSDIN family 
(see Figure 3) might also serve as a recognition sequence 
for cleavage by POP. PatA makes both cuts of the pa-
tellamides, like POP in the Amanita system.10 However, 
compared to the action of POP on a phalloidin precur-
sor, the activity of PatA is very slow.30 Cyclization of 
patellamides does not require an additional source of 
energy; it is apparently driven by coupling with the pro-
teolytic reaction.30 Searching of all sequenced fungi, in-
cluding A. bisporigera, have failed to find any orthologs 
of PatA or PatG (or any of the other genes of the patel-
lamide cluster), and so the mechanism of cyclization of 
the Amanita toxins is apparently different from the case 
of the cyanobactins.
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